RLS Global: The rights issue is registered and the trading in Paid Subscription Shares ceases
RLS Global AB (publ) (”RLS Global” or "the Company”) has completed a rights issue of shares that closed on 11 November, 2022. The rights issue is now registered with the Swedish Companies Registration Office and the last day for trading in paid subscribed shares ("BTA") will be Wednesday, December 14th, 2022. The record date will be December 16th, 2022, after which the BTAs are converted into ordinary shares on Tuesday December 20th, 2022.
The information was submitted for publication, through the agency of the contact persons set out below, on December 9th, 09.00 CEST.
TRADING PLACE AND CERTIFIED ADVISER:
RLS Global’s shares have been listed on the Nasdaq First North Growth Market since 17th May, 2017 and trading takes place under the short name RLS. Certified Adviser is Redeye Aktiebolag. During the period 2012–2017, the company was listed on Aktietorget.
FOR MORE INFORMATION, PLEASE CONTACT:
Björn Larsson, CEO, RLS Global
E-mail: [email protected]
Tel: +46 766 20 17 25
ABOUT RLS GLOBAL:
RLS Global AB is a medical technology company within Life Science. Based on the company's unique hypochlorite platform, RLS develops and sells products under the brand ChloraSolv® for indications within advanced wound care.
RLS's long-term vision is to be a leading research-driven platform company in wound care. The ambition is to expand to new indications through new research and development projects in areas such as burns and dermatology. To maximize market presence, RLS works with partners to commercialize products globally. RLS is convinced that the company's platform technology and its unique features will help many patients around the world. Read more at www.rls.global
Iconovo AB has completed a directed new share issue of SEK 55 million
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEELAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SWITZERLAND, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION OR RE...
Iconovo AB har genomfört en riktad nyemission om 55 miljoner SEK
EJ FÖR PUBLICERING, DISTRIBUTION, ELLER OFFENTLIGGÖRANDE, HELT ELLER DELVIS, DIREKT ELLER INDIREKT, I AUSTRALIEN, BELARUS, HONGKONG, JAPAN, KANADA, NYA ZEELAND, RYSSLAND, SCHWEIZ, SINGAPORE, SYDAFRIKA, USA ELLER NÅGON ANNAN JURISDIKTION DÄR SÅDAN HANDLING SKULLE VARA FÖRBJUDEN ENLIGT LAG ELLER KRÄVA...
CLS Americas and HALO Precision Diagnostics Announce 25 Patient Post-Market Study to Evaluate CLS’s TRANBERG Thermal Therapy System
IRVINE, Calif. and INDIAN WELLS, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, and HALO Precision Diagnostics, Inc. (HALO), today announced a Letter of Intent to e...
Clinical Laserthermia Systems signs LOI with HALO Precision Diagnostics for TRANBERG Thermal Therapy System
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announces that their US subsidiary CLS Americas has signed a Letter of Intent (LOI) with HALO Precision Diagnostics, Inc. (HALO) for evaluation of safety and short term efficacy of CLS’s TRANBERG® Thermal Therapy S...